We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.
- Authors
Terasaki, Mizuhiko; Shibui, Soichiro; Narita, Yoshitaka; Fujimaki, Takamitsu; Aoki, Tomokazu; Kajiwara, Koji; Sawamura, Yutaka; Kurisu, Kaoru; Mineta, Toshihiro; Yamada, Akira; Itoh, Kyogo
- Abstract
Personalized selection of suitable peptides for patients could offer a novel approach to developing cancer vaccines that boost anticancer immunity. We present the results of a phase I trial of 14 kinds of vaccine candidates (ITK-1) in patients with recurrent or progressive glioblastoma multiforme (GBM).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 3, p337
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.29.7499